VOLUME
68 2007 NUMBER 7
Editorial
989 Twenty Years at the Helm. Alan J. Gelenberg
[PDF]
Publisher Note
991 Twenty Years and Counting.
[PDF]
Original Articles
992 Shared Decision Making and Long-Term Outcome in Schizophrenia
Treatment. Johannes Hamann, Rudolf Cohen, Stefan Leucht, Raymonde Busch, and Werner
Kissling
[Abstract] [PDF]
998 Are Overweight, Obesity, and Extreme Obesity Associated With
Psychopathology? Results From the National Epidemiologic Survey on Alcohol
and Related Conditions. [CME]
Roger P. Pickering, Bridget F. Grant, S. Patricia Chou, and Wilson M.
Compton
[Abstract] [PDF]
1010 Levetiracetam as Adjunctive Therapy for Refractory Anxiety
Disorders. Gustavo Kinrys, John J. Worthington, Lisa Wygant, Fernanda Nery, Hannah
Reese, and Mark H. Pollack
[Abstract] [PDF]
1014 Prevention of Recurrent Episodes of Depression With Venlafaxine ER
in a 1-Year Maintenance Phase From the PREVENT Study. James H. Kocsis, Michael E. Thase, Madhukar H. Trivedi, Richard C.
Shelton, Susan G. Kornstein, Charles B. Nemeroff, Edward S. Friedman, Alan
J. Gelenberg, David L. Dunner, Robert M. A. Hirschfeld, Anthony J.
Rothschild, James M. Ferguson, Alan F. Schatzberg, John M. Zajecka, Ronald
D. Pedersen, Bing Yan, Saeed Ahmed, Jeff Musgnung, Philip T. Ninan, and
Martin B. Keller
[Abstract] [PDF]
1024 Selective Serotonin Reuptake Inhibitors in the Context of Hepatitis
C Infection: Reexamining the Risks of Bleeding. Kari A. Martin, Lois E. Krahn, Vijayan Balan, and Marianne J. Rosati
[Abstract] [PDF]
1027 Outcome Following Clozapine Discontinuation: A Retrospective
Analysis. James M. Atkinson, Petrina Douglas-Hall, Catrin Fischetti, Anna Sparshatt,
and David M. Taylor
[Abstract] [PDF]
1031 Efficacy of Piracetam in the Treatment of Tardive Dyskinesia in
Schizophrenic Patients: A Randomized, Double-Blind, Placebo-Controlled
Crossover Study. Igor Libov, Chanoch Miodownik, Yuly Bersudsky, Tzvi Dwolatzky, and
Vladimir Lerner
[Abstract] [PDF]
1038 Cost-Efficacy of Individual and Combined Treatments for Panic
Disorder. R. Kathryn McHugh, Michael W. Otto, David H. Barlow, Jack M. Gorman, M.
Katherine Shear, and Scott W. Woods
[Abstract] [PDF]
1045 Metabolic Syndrome Among Persons With Schizophrenia and Other
Psychotic Disorders in a General Population Survey. Jaana M. Suvisaari, Samuli I. Saarni, Jonna Perälä, Janne V. J. Suvisaari,
Tommi Härkänen, Jouko Lönnqvist, and Antti Reunanen
[Abstract] [PDF]
1056 A Meta-Analytic Review of Double-Blind, Placebo-Controlled Trials of
Antidepressant Efficacy of Omega-3 Fatty Acids. Pao-Yen Lin and Kuan-Pin Su
[Abstract] [PDF]
1062 Clinical Factors Associated With Treatment Resistance in Major
Depressive Disorder: Results From a European Multicenter Study. Daniel Souery, Pierre Oswald, Isabelle Massat, Ursula Bailer, Joseph
Bollen, Koen Demyttenaere, Siegfried Kasper, Yves Lecrubier, Stuart
Montgomery, Alessandro Serretti, Joseph Zohar, and Julien Mendlewicz, for
the Group for the Study of Resistant Depression (GSRD)
[Abstract] [PDF]
1071 Efficacy and Tolerability of Adjunctive Ziprasidone in
Treatment-Resistant Depression: A Randomized, Open-Label, Pilot Study. David L. Dunner, Jay D. Amsterdam, Richard C. Shelton, Antony Loebel, and
Steven J. Romano
[Abstract] [PDF]
1078 Persistent Neuropsychological Deficit in Euthymic Bipolar Patients:
Executive Function as a Core Deficit. Maria Mur, Maria J. Portella, Anabel Martínez-Arán, Josep Pifarré, and
Eduard Vieta
[Abstract] [PDF]
Focus on Childhood and Adolescent Mental Health
1087 To Medicate or Not to Medicate? Melissa P. DelBello
[PDF]
1088 An Open-Label Study of the Efficacy and Tolerability of Aripiprazole
for Children and Adolescents With Tic Disorders. Hanik K. Yoo, Soon-Ho Choi, Subin Park, Hee-Ryung Wang, Jin-Pyo Hong, and
Chang-Yoon Kim
[Abstract] [PDF]
1094 A Randomized, Placebo-Controlled Clinical Trial of Bupropion for the
Prevention of Smoking in Children and Adolescents With
Attention-Deficit/Hyperactivity Disorder. Michael C. Monuteaux, Thomas J. Spencer, Stephen V. Faraone, Angela M.
Wilson, and Joseph Biederman
[Abstract] [PDF]
1102 Positive Childhood Experiences: Resilience and Recovery From
Personality Disorder in Early Adulthood. [CME]
Andrew E. Skodol, Donna S. Bender, Maria E. Pagano, M. Tracie Shea,
Shirley Yen, Charles A. Sanislow, Carlos M. Grilo, Maria T. Daversa, Robert
L. Stout, Mary C. Zanarini, Thomas H. McGlashan, and John G. Gunderson
[Abstract] [PDF]
1109 Is Age-at-Onset Criterion Relevant for the Response to
Methylphenidate in Attention-Deficit/Hyperactivity Disorder? Marcelo C. Reinhardt, Lucia Benetti, Marcelo M. Victor, Eugenio H. Grevet,
Paulo Belmonte-de-Abreu, Stephen V. Faraone, and Luis A. Rohde
[Abstract] [PDF]
Academic Highlights
1117 Advances in the Treatment of Alcohol Dependence. [CME]
[PDF]
1129 Managing Bipolar Disorder From Urgent Situations to Maintenance
Therapy, Part 1: Urgent Situations. [CME]
[PDF]
Commentary
1139 The Revised Black Box Warning for Antidepressants Sets a Public
Health Experiment in Motion. Andrew C. Leon
[PDF]
ASCP Corner
1142 Dual Dependency on Cocaine and Alcohol in Opiate Addicts: Treatment
Options. Tracie Gardner and Thomas Kosten
[PDF]
A Psychiatrist's Diary
1144 Where Experts Are Many. Shyam K. Bhat
[PDF]
Letters To the Editor
1146 Bright Light Therapy for Negative Symptoms in Schizophrenia: A Pilot
Study. Wolfgang Aichhorn, Renate Stelzig-Schoeler, Christian Geretsegger,
Christoph Stuppaeck, and Georg Kemmler
[PDF]
1146 Dosing of Divalproex Extended Release. David Feifel
[PDF]
- Reply by Charles L. Bowden
1147 Eosinophilia Indicating Subclinical Clozapine-Induced Pericarditis.
Katrin Körtner, Andres H. Neuhaus, Falk Schürer, and Michael Dettling
[PDF]
1148 Quetiapine in Patients With Tourette's Disorder: An Open-Label,
Flexible-Dose Study. Jonas L. de Jonge, Danielle C. Cath, and Anton J. L. M.
van Balkom
[PDF]
1150 If Buddha Were in Treatment. Anthony Green
[PDF]
Book Reviews 1151
Electronic CME Activities
Available through www.psychiatrist.com/toc
e17
Identifying Metabolic Risks With Antipsychotics and Monitoring and
Management Strategies. John W. Newcomer and Michael J. Sernyak
e18
Diagnosing ADHD in Adults With Substance Use Disorder: DSM-IV
Criteria and Differential Diagnosis. Frances R. Levin and Himanshu P.
Upadhyaya
e19
Integrating General Health Care in Private Community Psychiatry
Practice. Donald C. Goff and John W. Newcomer |